نتایج جستجو برای: partial thromboplastin

تعداد نتایج: 231255  

Journal: :CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2011
Mark O Baerlocher Andy Myers Murray Asch

Before any interventional radiology procedure, including biopsy and abscess drainage, patients should have testing to determine the complete blood count (including platelet count), activated partial thromboplastin time and international normalized ratio. The tests should be done as close to the time of the procedure as possible. For stable patients, the timing of blood tests should be within on...

2017

Submit Manuscript | http://medcraveonline.com Abbreviations: APDE: Acquired Platelet Dysfunction with Eosinophilia; AEC: Absolute Eosinophil Count; ADP: Adenosine Diphosphate; RiCof: Platelet Ristocetin Cofactor; APTT: Activated Partial Thromboplastin Time; PT: Prothrombin Time; SFLC: Serum Free Light Chains; IgA: Immunoglobulin A; aVWD: Acquired Von Willebrand Disease; FVIII: Factor VIII; FIX:...

Journal: :Cases Journal 2008
Martial Koenig Jérôme Morel Jacqueline Reynaud Cécile Varvat Pascal Cathébras

We report the case of a 39-year old male patient who presented with anaphylactoid shock and diffuse bleeding with prolonged activated partial thromboplastin time at the emergency room. The diagnosis of aggressive mastocytosis was suspected and then confirmed by raised tryptase level and mastocytic infiltration of the bone marrow. The outcome was favorable with supportive measures, antihistamine...

Journal: :Anesthesiology 2014
Niels Rahe-Meyer Hein Fennema Sam Schulman Walter Klimscha Michael Przemeck Manfred Blobner Hinnerk Wulf Marcel Speek Christine McCrary Sisk Debora Williams-Herman Tiffany Woo Armin Szegedi

BACKGROUND Previous studies show a prolongation of activated partial thromboplastin time and prothrombin time in healthy volunteers after treatment with sugammadex. The authors investigated the effect of sugammadex on postsurgical bleeding and coagulation variables. METHODS This randomized, double-blind trial enrolled patients receiving thromboprophylaxis and undergoing hip or knee joint repl...

Journal: :Circulation 2008
Mark Y Chan Mauricio G Cohen Christopher K Dyke Shelley K Myles Laura G Aberle Min Lin James Walder Steven R Steinhubl Ian C Gilchrist Neal S Kleiman David A Vorchheimer Nicholas Chronos Chiara Melloni John H Alexander Robert A Harrington Ross M Tonkens Richard C Becker Christopher P Rusconi

BACKGROUND Whether selective factor IXa inhibition produces an appropriate anticoagulant effect when combined with platelet-directed therapy in patients with stable coronary artery disease is unknown. REG1 consists of RB006 (drug), an injectable RNA aptamer that specifically binds and inhibits factor IXa, and RB007 (antidote), the complementary oligonucleotide that neutralizes its anti-IXa acti...

Journal: :Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999
E Abderrahim F Ben Moussa T Ben Abdallah H Hedri R Goucha F Ben Hamida F El Younsi A Kheder H Ben Maiz

Key words: adult glomerulocystic kidney disease; end-cell counts and platelets were normal, as were prothrombin and partial thromboplastin times. Serum stage renal failure; renal biopsy concentrations of albumin and gamma globulins were normal. Total haemolytic complement, C 3 and C 4 were within normal range and the Wassermann reaction was

Journal: :Journal of clinical pathology 1962
C GARDIKAS C LYBERATOS G KALLINIKOS M KALLINIKOU

The activities of the Prower-Stuart factor in the first and second phase of thromboplastin production were separately assayed in 100 normal persons and 50 Dindevan-treated patients. It was found that in some of the subjects examined the two activities varied independently, and that some of the normal persons presented a partial deficiency of the factor. The implications of these findings are di...

2016
Haseeb A. Khan

AMI: Acute Myocardial Infarction; aPTT, Activated Partial Thromboplastin Time; CCSP: Clinical Coronary Stenosis Progression; CK: Creatine Kinase; CRP: C-reactive Protein; CVD: Cerebrovascular Disease; CVP: Cerebral Vasculopathies; HDL: High Density Lipoprotein; LDL: Low Density Lipoprotein; Lp(a): Lipoprotein (a); MACE: Major Adverse Cardiac Event; PAI-1: Plasminogen Activator Inhibitor-1; PT: ...

Journal: :Blood 1990
L V Rao S I Rapaport

Infusing factor VIIa (FVIIa) has been reported to control bleeding in hemophilic patients with factor VIII (FVIII) inhibitors. This is difficult to attribute to an enhanced FVIIa/tissue factor (TF) activation of factor X, since in vitro studies suggest that infusion of FVIIa should neither increase substantially the rate of formation of FVIIa/TF complexes during hemostasis (Proc Natl Acad Sci U...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید